Laserfiche WebLink
The public hearing will then be closed. The Planning Commissioners then discuss among themselves the application under <br /> consideration and act on the item. Planning Commission actions may be appealed to the City Council. Appeals must be filed <br /> with the City Clerk's Office within 15 days of the Planning Commission's action. <br /> The Planning Commission Chair may enforce other rules as may further the fair and efficient running of the meeting, such as <br /> reducing the amount of testimony time allotted to the applicant and all those who wish to speak when the meeting agenda is <br /> lengthy or when there are numerous speakers for any specific item. The audience is requested to respect and extend courtesy <br /> to all those wishing to testify on all cases by being quiet while others are speaking. <br /> ************************************** <br /> Reso No. PC-2021-06 <br /> CALL TO ORDER, PLEDGE OF ALLEGIANCE, AND ROLL CALL <br /> AGENDA AMENDMENTS <br /> CONSENT CALENDAR - Consent Calendar items are considered routine and will be enacted by one <br /> motion unless a request for removal for discussion or explanation is received from the Planning <br /> Commission or a member of the public by submitting a speaker card for that item. <br /> 1. Actions of the Zoning Administrator <br /> MEETING OPEN TO THE PUBLIC <br /> 2. Public Comment from the audience regarding items not listed on the agenda — Speakers are <br /> encouraged to limit comments to 3 minutes. <br /> PUBLIC HEARINGS AND OTHER MATTERS <br /> 3. PUD-139 and P20-0973, 10x Genomics, Inc., 1701 Springdale Avenue — Applications for: (1) a <br /> Planned Unit Development (PUD) Rezoning to rezone the subject parcel from C-R (p) (Regional <br /> Commercial - peripheral sites) District to PUD-C-O (Planned Unit Development — Commercial- <br /> Office) District; (2) a PUD Development Plan to construct up to three new multi-story research and <br /> development, office and laboratory buildings totaling approximately 381,000 square feet, a parking <br /> structure, and related site improvements over multiple phases; as well as (3) make a finding of <br /> General Plan conformity for a related Development Agreement to vest the entitlements for the PUD <br /> Rezoning and Development Plan. <br /> MATTERS FOR COMMISSION'S REVIEW/ACTION/INFORMATION <br /> 4. Reports from Meetings Attended (e.g., Committee, Task Force, etc.) <br /> 5. Actions of the City Council <br /> 6. Future Planning Calendar <br /> MATTERS INITIATED BY COMMISSION MEMBERS <br /> ADJOURNMENT <br /> Planning Commission Agenda Page 2 of 3 May 26, 2021 <br />estimony. <br /> • Following public testimony, the applicant will be given the opportunity to respond to issues raised by the public.The <br /> response should be limited to five minutes. <br />lanning Commission <br /> 31 of 32 <br />erty. A <br /> development agreement is a commitment between the City and a property owner or developer <br /> to proceed with a specific development in accordance with the terms of an agreement that <br /> describes what land use and related processes shall apply to the application. In essence, a <br /> development agreement locks in the laws in existence at the time of entering into the <br /> agreement and the City agrees not to change its planning or zoning laws applicable to the <br /> specific development project for a specified period. Therefore, future land use decisions <br /> regarding such a development project would not be based on then current planning and zoning <br /> law, but rather they would be based on the laws in existence at the time the development <br /> agreement was executed. The developer gains certainty, through the development agreement, <br /> of the continuity of regulations in force at the time of entering into the development agreement <br /> and prior to a commitment of a substantial investment for project improvements. In exchange, <br /> PUD-139 and P20-0973, 10x Genomics, Inc. Planning Commission <br /> 30 of 32 <br />and primary)). <br /> PUD-139 and P20-0973, 10x Genomics, Inc. Planning Commission <br /> 19 of 32 <br /><br />